Cytisiniclinum
This medicine should always be taken exactly as described in this package leaflet for the patient or as directed by a doctor, pharmacist, or nurse.
Smoking cessation and reduction of nicotine craving in adult smokers who want to stop smoking. The use of the medicinal product Exicyt allows for gradual reduction of nicotine dependence and weaning from smoking tobacco without nicotine withdrawal symptoms (e.g. decreased mood, irritability, anxiety, concentration difficulties, insomnia, increased appetite). The goal of using Exicyt is permanent cessation of using nicotine-containing products.
Exicyt should be used with caution in patients with ischemic heart disease, heart failure, hypertension, pheochromocytoma, atherosclerosis (arteriosclerosis) and other peripheral vascular diseases, gastric and duodenal ulcer disease, gastroesophageal reflux disease, hyperthyroidism, diabetes, schizophrenia, renal and hepatic impairment. Exicyt should only be taken by individuals with a serious intention to quit smoking tobacco. Taking Exicyt and continuing to smoke tobacco or using nicotine-containing products may lead to increased nicotine side effects.
Due to limited experience, it is not recommended to use Exicyt in persons under 18 years of age.
Due to limited clinical experience, it is not recommended to use Exicyt in the elderly over 65 years of age.
There is no clinical experience with Exicyt in patients with liver and kidney function disorders, therefore its use is not recommended in this group of patients.
Tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take. Do not take Exicyt with anti-tuberculosis medicines. In some cases, as a result of quitting smoking, with or without the use of Exicyt, it may be necessary to adjust the doses of other medicines. This is especially important if you are taking medicines containing theophylline (used in asthma), tacrine (used in Alzheimer's disease), clozapine (used in schizophrenia), and ropinirole (used in Parkinson's disease). If in doubt, consult your doctor or pharmacist. It is currently unknown whether Exicyt can reduce the effectiveness of systemic hormonal contraceptives. Women using systemic hormonal contraceptives should use an additional barrier method (e.g. condoms).
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, ask your doctor or pharmacist for advice before taking this medicine. Women of childbearing potential must use effective contraception during treatment with Exicyt. Consult your doctor. Exicyt is contraindicated during pregnancy and breastfeeding.
Exicyt has no influence on the ability to drive and use machines.
Changes in the body associated with quitting smoking, as a result of using Exicyt or not, may change the way other medicines work. Therefore, in some cases, it may be necessary to adjust the doses of other medicines. More information can be found above in the "Exicyt and other medicines" section. In some people, quitting smoking, with or without the use of medicines, has been associated with an increased risk of changes in thinking or behavior, feelings of depression and anxiety (including rare suicidal thoughts and attempts) and may be associated with worsening of psychiatric disorders. If you have or have had psychiatric disorders, you should discuss this with your doctor. Aspartame This medicine contains 0.12 mg of aspartame (E 951) per coated tablet. Aspartame is a source of phenylalanine. It may be harmful to patients with phenylketonuria. This is a rare genetic disorder in which phenylalanine accumulates in the body due to its improper excretion.
This medicine should always be taken exactly as described in the package leaflet for the patient or as directed by a doctor or pharmacist. If in doubt, consult your doctor or pharmacist. One package of Exicyt (100 tablets) is sufficient for a full course of treatment. The treatment duration is 25 days. Exicyt is intended for oral use, it should be taken with a sufficient amount of water according to the scheme below.
From day 1 to 3 1 tablet every 2 hours 6 tablets From day 4 to 12 1 tablet every 2.5 hours 5 tablets From day 13 to 16 1 tablet every 3 hours 4 tablets From day 17 to 20 1 tablet every 5 hours 3 tablets From day 21 to 25 1-2 tablets per day up to 2 tablets The blister is marked with consecutive days of taking Exicyt. You should stop smoking no later than on the 5th day of treatment. During treatment, do not continue smoking, as this may increase side effects. If you are unable to stop smoking within 5 days of starting treatment with Exicyt, you should contact your doctor. If the treatment result is unsatisfactory, you should stop treatment and restart it after 2 to 3 months.
Exicyt is not recommended for use in persons under 18 years of age.
Symptoms of Exicyt overdose are characteristic of nicotine poisoning symptoms. Overdose symptoms are malaise, nausea, vomiting, increased heart rate, blood pressure fluctuations, respiratory disorders, vision disorders, seizures. If any of the described symptoms occur or a symptom that has not been listed in this leaflet, you should stop taking Exicyt and contact your doctor or pharmacist.
Do not take a double dose to make up for a missed dose.
If you have further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Exicyt can cause side effects, although not everybody gets them. The following side effects may occur with the frequency shown below: Very common - may affect more than 1 in 10 people:change in appetite (mainly increased), weight gain, dizziness, irritability, mood changes, anxiety, increased blood pressure (hypertension), dry mouth, diarrhea, rash, fatigue, sleep disorders (insomnia, drowsiness, lethargy, strange dreams, nightmares), headaches, increased heart rate, nausea, taste changes, heartburn, constipation, vomiting, abdominal pain (especially in the upper abdomen), muscle pain. Common - may affect up to 1 in 10 people:concentration difficulties, slowed heart rate, bloating, tongue burning, malaise. Uncommon - may affect up to 1 in 100 people:feeling of heaviness in the head, decreased sex drive, tearing, shortness of breath, increased coughing, excessive salivation, increased sweating, decreased skin elasticity, fatigue, increased liver enzyme activity. Most of the side effects listed above occur mainly in the initial period of treatment and subside with its duration. These symptoms may also be the result of quitting smoking tobacco (withdrawal symptoms), not taking Exicyt.
If you experience any side effects, including any not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl By reporting side effects, you can help provide more information on the safety of this medicine. Side effects can also be reported to the marketing authorization holder.
Keep this medicine out of the sight and reach of children. Store in the original package to protect from light. Do not use this medicine after the expiry date stated on the blister and carton after EXP. The expiry date refers to the last day of that month. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
What Exicyt contains
Exicyt is a round, biconvex, coated tablet, light green to greenish, with a diameter of 5 mm. PVC/PVDC/Aluminum blisters placed in a cardboard box containing 100 coated tablets.
Adamed Pharma S.A. Pieńków, ul. M. Adamkiewicza 6A 05-152 Czosnów
Adamed Pharma S.A. ul. Marszałka J. Piłsudskiego 5 95-200 Pabianice Poland
Poland: Exicyt Czech Republic: Heavis Date of last revision of the leaflet:October 2023
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.